BMC Medicine: a decade of open access medical research
BMC Medicine 2014, 12:4 (9 January 2014)
It has been 10 years since we have been publishing open access medical research, so we take a look at some of the most notable milestones for the journal and our editorial board members discuss exciting developments in their own fields of medicine.
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
BMC Medicine 2013, 11:221 (17 October 2013)
Translation of tumor biomarker tests to clinical trials should be based on robust evidence; Dan Hayes discusses a new checklist that researchers should follow for stringent methodology, highlighting its importance for clinical application.
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
BMC Medicine 2013, 11:220 (17 October 2013)
Lisa McShane and colleagues present a checklist of criteria to address the lack of scientific rigor when evaluating preclinical evidence to support translation of omics-based predictors to clinical trials, providing a useful resource for researchers.